171 related articles for article (PubMed ID: 37936892)
1. Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO
Wang Z; Li Z; Shi Y; Zeng L
Regen Biomater; 2023; 10():rbad087. PubMed ID: 37936892
[TBL] [Abstract][Full Text] [Related]
2. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous polydopamine-based nanoplatform for enhanced tumor chemodynamic therapy through the reducibility weakening strategy.
Zhang Q; Xu X; Yang Q; Duan Y; Chen C; Zhao S; Ouyang Y; Chen Y; Cao Y; Liu H
Colloids Surf B Biointerfaces; 2023 Feb; 222():113091. PubMed ID: 36542951
[TBL] [Abstract][Full Text] [Related]
4. Hollow mesoporous MnO
He H; Yang Q; Li H; Meng S; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Mar; 188(4):141. PubMed ID: 33774694
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment responsive theranostic agent for enhanced chemo/chemodynamic/photothermal therapy.
Wang J; Kong W; Jin H; Li C; Luo Q; Luo Y; Yuan C; Lu J; Zhang L; Liu X
Colloids Surf B Biointerfaces; 2022 Oct; 218():112750. PubMed ID: 35961116
[TBL] [Abstract][Full Text] [Related]
6. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
7. Ultrasmall Gold-Coated Mesoporous Polydopamine Nanoprobe to Enhance Chemodynamic Therapy by Self-Supplying H
Wang Z; Shi Y; Shi Y; Zhang J; Hao R; Zhang G; Zeng L
ACS Appl Mater Interfaces; 2022 Dec; 14(49):54478-54487. PubMed ID: 36448730
[TBL] [Abstract][Full Text] [Related]
8. Endo/exo-genous dual-stimuli responsive gold nanotetrapod-based nanoprobe for magnetic resonance imaging and enhanced multimodal therapeutics by amplifying·OH generation.
Shi Y; Zeng L; Pan Y; Zhang H; Wang Z; Shi Y; Wu A
Acta Biomater; 2022 Dec; 154():549-558. PubMed ID: 36243375
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment responsive hollow mesoporous Co
Huang J; Huang Y; Xue Z; Zeng S
Biomaterials; 2020 Dec; 262():120346. PubMed ID: 32927232
[TBL] [Abstract][Full Text] [Related]
11. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-modified manganese dioxide-enveloped hollow copper sulfide nanoparticles as a multifunctional system for the co-delivery of chemotherapeutic drugs and photosensitizers for efficient synergistic antitumor treatments.
Li X; Pan Y; Zhou J; Yi G; He C; Zhao Z; Zhang Y
J Colloid Interface Sci; 2022 Jan; 605():296-310. PubMed ID: 34329981
[TBL] [Abstract][Full Text] [Related]
13. Multi-stimuli responsive hollow MnO
Xu X; Duan J; Liu Y; Kuang Y; Duan J; Liao T; Xu Z; Jiang B; Li C
Acta Biomater; 2021 May; 126():445-462. PubMed ID: 33785453
[TBL] [Abstract][Full Text] [Related]
14. Precisely NIR-II-activated and pH-responsive cascade catalytic nanoreactor for controlled drug release and self-enhanced synergetic therapy.
Hu P; Zhao S; Shi J; Li F; Wang S; Gan Y; Liu L; Yu S
Nanoscale; 2022 Sep; 14(34):12219-12231. PubMed ID: 35582977
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of doxorubicin-gated mesoporous polydopamine nanoplatforms for multimode imaging-guided synergistic chemophotothermal therapy of tumors.
Yang M; Zhang N; Zhang T; Yin X; Shen J
Drug Deliv; 2020 Dec; 27(1):367-377. PubMed ID: 32091284
[TBL] [Abstract][Full Text] [Related]
16. In vitro Antitumor Properties of Fucoidan-Coated, Doxorubicin-Loaded, Mesoporous Polydopamine Nanoparticles.
Xu H; Ling J; Zhao H; Xu X; Ouyang XK; Song X
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500550
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer.
Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J
ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056
[TBL] [Abstract][Full Text] [Related]
18. A mesoporous MnO
Zhang HL; Wang Y; Tang Q; Ren B; Yang SP; Liu JG
J Inorg Biochem; 2023 Apr; 241():112133. PubMed ID: 36708626
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe
Shu G; Chen M; Song J; Xu X; Lu C; Du Y; Xu M; Zhao Z; Zhu M; Fan K; Fan X; Fang S; Tang B; Dai Y; Du Y; Ji J
Bioact Mater; 2021 May; 6(5):1423-1435. PubMed ID: 33210034
[TBL] [Abstract][Full Text] [Related]
20. A tetrasulfide bond-bridged mesoporous organosilica-based nanoplatform for triple-enhanced chemodynamic therapy combined with chemotherapy and H
Liu M; Xu H; Zhou F; Gong X; Tan S; He Y
J Mater Chem B; 2023 Nov; 11(45):10822-10835. PubMed ID: 37920970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
